SCHEMBL6949324

SCHEMBL6949324

Cc1nc(NCCCN2CCOCC2)c([N+](=O)[O-])c(N2CCc3ccccc3CC2)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.52
LMNA P02545 2/20 0.52
HTT P42858 3/20 0.51
MAPK1 P28482 3/20 0.51
POLB P06746 4/20 0.48
MAPT P10636 7/20 0.47
ALDH1A1 P00352 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
GSK3A P49840 3/20 0.45
GSK3B P49841 3/20 0.45
PKM P14618 1/20 0.43
TP53 P04637 2/20 0.42
USP2 O75604 1/20 0.42
GLA P06280 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
ALOX15 P16050 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6945708 0.85 GRIN2D (0.39) KDM4ELMNAHTTPOLBMAPT
SCHEMBL6947657 0.85 GRIN2D (0.39) KDM4ELMNAHTTPOLBMAPT
SCHEMBL6949237 0.84 ADORA1 (0.46) KDM4ELMNAHTTMAPK1POLB
SCHEMBL6949344 0.82 ALDH1A1 (0.52) KDM4ELMNAHTTMAPK1POLB
SCHEMBL6950446 0.80 SMN1; SMN2 (0.56) KDM4ELMNAMAPK1MAPTALDH1A1
SCHEMBL6954763 0.78 GAA (0.47) KDM4ELMNAHTTMAPK1MAPT
SCHEMBL6956884 0.76 GAA (0.52) KDM4ELMNAMAPK1MAPTALDH1A1
SCHEMBL3404172 0.74 MAPT (0.48) KDM4ELMNAHTTMAPK1POLB
SCHEMBL6947517 0.73 MEN1 (0.44) HTTMAPK1POLBMAPTALDH1A1
SCHEMBL6949469 0.71 POLB (0.43) HTTMAPK1POLBMAPTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed